Regulatory Information
UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
Therapeutic
Pharmacy Only
Formulation Information
GRANULE
**POSOLOGY** Adults and children above 6 years - 1 sachet FLUIMUCIL® 200mg or 2 sachets FLUIMUCIL® 100mg, 2–3 times a day; Children (2–6 years of age) - 1 sachet FLUIMUCIL® 100 mg from 2 to 4 times a day, according to the age. The duration of treatment should be 5 to 10 days in the acute treatment, whereas it may be continued in the chronic states for several months, according to the advice of the physician. **MODALITY OF USE** Dissolve the contents of the sachets in a glass containing a small quantity of water, mixing it, if necessary, with a spoon. A palatable solution is thus obtained, to be drunk immediately.
ORAL
Medical Information
**INDICATIONS** FLUIMUCIL® is indicated as an adjuvant treatment in certain clinical condition characterized by the presence of thick and viscous mucoid or mucopurulent secretions such as: - Chronic bronchopulmonary diseases (chronic obstructive pulmonary disease, emphysema with bronchitis, chronic asthmatic bronchitis, bronchiectasis); - Acute bronchopulmonary diseases (asthma with bronchial mucus plugging, bronchitis, bronchopneumonia, tracheobronchitis, bronchiolitis, pulmonary complications of cystic fibrosis, pulmonary complications associated with surgery).
**CONTRAINDICATIONS** Known hypersensitivity to acetylcysteine or to any of the excipients (please see below the section Warning and Precautions – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_) Children under 2 years of age.
R05CB01
acetylcysteine
Manufacturer Information
UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
ZAMBON SWITZERLAND LTD
Active Ingredients
Documents
Patient Information Leaflets
Fluimucil Sachet 100mg an 200mg PIL.pdf
Approved: December 19, 2017